Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report

Blood Res. 2023 Jun 30;58(2):118-120. doi: 10.5045/br.2023.2023061. Epub 2023 Jun 14.

Authors

Sabrine Mekni^{1

2}, Rimmel Yosra Kanoun^{1

2}, Saloua Ladeb^{1

2}, Dorra Belloumi^{1

2}, Nour Ben Abdeljelil^{1

2}, Tarek Ben Othman^{1

2}

Affiliations

¹ Department of Hematology, National Center of Stem Cell Transplantation, Tunis, Tunisia.
² Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.

No abstract available

Publication types

Letter